Have you modified prescribing practices in light of the UK safety update noting risk of neurodevelopmental disorders in children whose fathers took valproic acid in the 3 months before conception.
https://www.gov.uk/drug-safety-update/valproate-re-analysis-of-study-on-risks-in-children-of-men-taking-valproate